BWXT BWX Technologies Inc

BWX Technologies manufactures nuclear components and provides services to the US government, including naval nuclear reactors and clean energy solutions. Sector: Industrials.

BWX Technologies Inc (BWXT) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

From a returns-on-capital standpoint, ROIC is 9.46%, WACC is 8.01%, and the economic spread is 1.45%. On balance, the company clears its capital cost hurdle modestly — value creation is present but not emphatic. Supporting metrics show ROE at 28.34% and ROA at 7.62%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that is value-creative but with less room for execution slippage.

The company's current market valuation reflects trailing P/E of 60.13, forward P/E of 46.71, PEG of 10.01. Forward P/E is significantly below trailing, indicating that consensus expects earnings to grow — making the company appear cheaper when viewed on anticipated profits. Growth-adjusted valuation is stretched here — the multiple implies either above-consensus growth or a willingness to pay a premium for quality. The aggregate current ratio of 2.32 points to adequate liquidity for the company. Across multiples and liquidity, the company is priced in a way that reflects current expectations reasonably well — leaving limited room for error, but also limited near-term downside from valuation compression alone.

On profitability at each income statement layer, gross margin sits at 22.91%, operating margin at 10.39%, and free cash flow margin at 9.23%. Gross margins are moderate, pointing to the company where unit economics are functional but not a source of structural advantage. The operating margin reading is modest, consistent with businesses still working to scale their cost structures efficiently. Free cash flow margins are moderate, with a meaningful but not exceptional share of revenue converting to cash after capex. Taken together, margins are adequate but uneven, suggesting earnings quality is not uniformly strong across all levels.

Looking at growth and market-implied direction, TTM revenue growth of 18.70% indicating top-line growth that is constructive without being speculative. At the same time, the estimated 12-month price change of 3.69%, where consensus pricing points to a narrow upside range. It's worth distinguishing between what businesses are actually delivering and what the market is being asked to believe about the next 12 months. Maintaining alignment between reported results and forward estimates is particularly important in periods where macro uncertainty is elevated. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The metrics do not present an obvious case for aggressive action in either direction, and a measured, monitoring posture is appropriate given the current mix of signals.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.